Risk of septic arthritis in patients with rheumatoid - The British ...

More documents

Recommendations

Info

BSRBR Disclosure Statement BSR receives restricted income financial support from Abbott Laboratories, Amgen, Biovitrum, Schering Plough, Wyeth Pharmaceuticals and Roche. This income finances a separate contract between the BSR and the University of Manchester who provide and run the BSRBR. All decisions concerning analysis, interpretation and publications are made autonomously of any industrial contribution. (I have no personal disclosures or conflicts of interest.)
Septic Arthritis • Septic arthritis (SA) increased in RA Explanations: • RA itself a risk for infection • Damaged joints more susceptible to colonisation • Presence of joint prostheses • Immunosuppressive therapy
Page 1: Risk of septic arthritis in patient
Page 5 and 6: Anti-TNF therapy and infection 5.0
Page 7 and 8: Aims • To establish the effect of
Page 9 and 10: BSR Biologics Register Control Coho
Page 11 and 12: Case validation • Physician confi
Page 13 and 14: Baseline characteristics DMARD Anti
Page 15 and 16: Results Septic Arthritis within the
Page 17 and 18: Pattern of cultured organisms Anti-
Page 19 and 20: Native joint infection • Approxim
Page 21: Acknowledgements • UK Consultant

Risk of septic arthritis in patients with rheumatoid - The British ...

Create successful ePaper yourself

Delete template?

Save as template?